Azitra Inc (AZTR) Stock Price, Quote & News - Mboum

Company Profile

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular ras...

Industry: Biotechnology

Sector: Healthcare

Phone: 203 646 6446

Website: azitrainc.com

Address:

21 Business Park Drive, Branford, United States

Joby099 Aug. 31 at 1:48 PM

0 · Reply

Rangort22 Aug. 31 at 1:02 PM

$AZTR something is brewing.

0 · Reply

Rangort22 Aug. 31 at 1:01 PM

$AZTR this will go this week.

0 · Reply

Joby099 Aug. 30 at 1:08 PM

0 · Reply

RichRich48 Aug. 29 at 9:08 PM

0 · Reply

WadehN21 Aug. 29 at 8:36 PM

0 · Reply

Boogie765 Aug. 29 at 7:34 PM

$AZTR Don't let them cover for cheap.

0 · Reply

ROCKET_MAGIC Aug. 29 at 7:28 PM

$AZTR 🌟🌟🌟 I was bearish yesterday. It went down to .90. There is a gap up from $.75 to over a dollar that I expected to fill, and probably will in a flash at some point. For now the volume and momentum is up. For now. Good luck!

0 · Reply

Rangort22 Aug. 29 at 7:16 PM

$AZTR gotta push thru this level

0 · Reply

alexvas95 Aug. 29 at 6:42 PM

$AZTR looks like EQ before it took off, I’m telling you. Let’s break $1.09

0 · Reply

Latest News on AZTR

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Aug 27, 2025, 8:10 AM EDT - 4 days ago

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Stock Market Today: Nasdaq, Dow, S&P 500 Futures Rise Ahead Of Powell's Speech At Jackson Hole—EpicQuest, Zoom, Azitra Stocks In Focus

Aug 22, 2025, 6:01 AM EDT - 9 days ago

Stock Market Today: Nasdaq, Dow, S&P 500 Futures Rise Ahead Of Powell's Speech At Jackson Hole—EpicQuest, Zoom, Azitra Stocks In Focus

IVV SPLG SPXL SPY SSO UPRO VOO

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Aug 11, 2025, 5:00 PM EDT - 20 days ago

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Azitra, Inc. Announces Reverse Stock Split

Aug 11, 2025, 4:15 PM EDT - 20 days ago

Azitra, Inc. Announces Reverse Stock Split

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Jun 17, 2025, 8:02 AM EDT - 2 months ago

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Jun 10, 2025, 8:33 AM EDT - 2 months ago

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

May 28, 2025, 8:33 AM EDT - 3 months ago

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

May 14, 2025, 4:05 PM EDT - 3 months ago

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

May 13, 2025, 5:06 PM EDT - 3 months ago

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Apr 25, 2025, 8:33 AM EDT - 4 months ago

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Apr 24, 2025, 4:05 PM EDT - 4 months ago

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Azitra to Present at Microbiome Times Partnering Forum

Mar 12, 2025, 8:33 AM EDT - 6 months ago

Azitra to Present at Microbiome Times Partnering Forum

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Feb 24, 2025, 8:30 AM EST - 6 months ago

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Feb 4, 2025, 2:20 PM EST - 7 months ago

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Feb 3, 2025, 9:05 AM EST - 7 months ago

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Azitra, Inc. to Present at The Microcap Conference

Jan 27, 2025, 4:05 PM EST - 7 months ago

Azitra, Inc. to Present at The Microcap Conference

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Jan 15, 2025, 8:30 AM EST - 8 months ago

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Azitra Announces Proposed Public Offering of Common Stock

Jan 14, 2025, 4:05 PM EST - 8 months ago

Azitra Announces Proposed Public Offering of Common Stock

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Nov 12, 2024, 5:05 PM EST - 10 months ago

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Azitra to Present at BIO-Europe 2024

Oct 29, 2024, 9:00 AM EDT - 10 months ago

Azitra to Present at BIO-Europe 2024

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 11, 2024, 9:00 AM EDT - 11 months ago

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Sep 24, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Sep 18, 2024, 9:00 AM EDT - 1 year ago

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 6, 2024, 4:30 PM EDT - 1 year ago

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 28, 2024, 8:30 AM EDT - 1 year ago

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Aug 22, 2024, 9:00 AM EDT - 1 year ago

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 20, 2024, 4:15 PM EDT - 1 year ago

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

Aug 12, 2024, 6:23 PM EDT - 1 year ago

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

Jul 25, 2024, 5:57 PM EDT - 1 year ago

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

Jul 25, 2024, 1:54 PM EDT - 1 year ago

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

Wingspire Equipment Finance's $12 Million Funding Initiative to Propel Tier 1 Aerospace Manufacturer Capabilities

Jul 25, 2024, 1:13 PM EDT - 1 year ago

Wingspire Equipment Finance's $12 Million Funding Initiative to Propel Tier 1 Aerospace Manufacturer Capabilities

Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

Jul 23, 2024, 9:20 PM EDT - 1 year ago

Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents

Jul 23, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

May 31, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

May 17, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

May 10, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates

May 9, 2024, 5:00 PM EDT - 1 year ago

Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates

Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting

Apr 22, 2024, 4:30 PM EDT - 1 year ago

Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting

Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024

Apr 18, 2024, 4:15 PM EDT - 1 year ago

Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024

Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates

Mar 15, 2024, 4:15 PM EDT - 1 year ago

Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates

Azitra, Inc. Announces Closing of Public Offering

Feb 16, 2024, 4:05 PM EST - 1 year ago

Azitra, Inc. Announces Closing of Public Offering

Azitra, Inc. Announces Pricing of Public Offering

Feb 13, 2024, 10:09 PM EST - 1 year ago

Azitra, Inc. Announces Pricing of Public Offering

Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US

Jan 16, 2024, 9:00 AM EST - 1 year ago

Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US

Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference

Jan 3, 2024, 9:00 AM EST - 1 year ago

Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference

Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates

Nov 14, 2023, 4:30 PM EST - 1 year ago

Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates

Azitra to Present at the ThinkEquity Conference

Oct 16, 2023, 8:00 AM EDT - 2 years ago

Azitra to Present at the ThinkEquity Conference

Azitra to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 29, 2023, 8:00 AM EDT - 2 years ago

Azitra to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates

Aug 14, 2023, 4:05 PM EDT - 2 years ago

Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates

Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors

Jul 19, 2023, 4:05 PM EDT - 2 years ago

Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors

Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer

Jul 11, 2023, 4:05 PM EDT - 2 years ago

Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer

Joby099 Aug. 31 at 1:48 PM

0 · Reply

Rangort22 Aug. 31 at 1:02 PM

$AZTR something is brewing.

0 · Reply

Rangort22 Aug. 31 at 1:01 PM

$AZTR this will go this week.

0 · Reply

Joby099 Aug. 30 at 1:08 PM

0 · Reply

RichRich48 Aug. 29 at 9:08 PM

0 · Reply

WadehN21 Aug. 29 at 8:36 PM

0 · Reply

Boogie765 Aug. 29 at 7:34 PM

$AZTR Don't let them cover for cheap.

0 · Reply

ROCKET_MAGIC Aug. 29 at 7:28 PM

$AZTR 🌟🌟🌟 I was bearish yesterday. It went down to .90. There is a gap up from $.75 to over a dollar that I expected to fill, and probably will in a flash at some point. For now the volume and momentum is up. For now. Good luck!

0 · Reply

Rangort22 Aug. 29 at 7:16 PM

$AZTR gotta push thru this level

0 · Reply

alexvas95 Aug. 29 at 6:42 PM

$AZTR looks like EQ before it took off, I’m telling you. Let’s break $1.09

0 · Reply

ROCKET_MAGIC Aug. 29 at 6:40 PM

$AZTR 🌟🌟🌟🌟🌟 Shhhhh it’s quietly up +20% since .90 yesterday.

2 · Reply

Rangort22 Aug. 29 at 6:25 PM

$AZTR maybe shorts starting to cover???

0 · Reply

Rangort22 Aug. 29 at 6:25 PM

$AZTR nice buys !!!

0 · Reply

Rangort22 Aug. 29 at 6:24 PM

$AZTR slow ride to 1.2 1.25

0 · Reply

Rangort22 Aug. 29 at 6:03 PM

$AZTR waiting for shorts to cover. Must be looking for shares. No one is selling.

0 · Reply

triclkbao1 Aug. 29 at 5:19 PM

$AZTR one day it will be like IPDN today.

0 · Reply

Rangort22 Aug. 29 at 4:52 PM

$AZTR slap that ask !

0 · Reply

WadehN21 Aug. 29 at 3:54 PM

$AZTR Looking good for a run

0 · Reply

Carlosxvice Aug. 29 at 3:49 PM

$AZTR dead cat bounce?

1 · Reply

Rangort22 Aug. 29 at 3:43 PM

$AZTR zero available

0 · Reply

Rangort22 Aug. 29 at 3:42 PM

0 · Reply

Rangort22 Aug. 29 at 3:40 PM

$AZTR lets go !

0 · Reply